Trial intelligence / Profile preview

Topical platelet-rich plasma for healing chronic venous leg ulcers

2017-000314-29Phase 4Active

Sponsor
Hospital Universitario La Paz
Start
Mar 2017
Modality
Cell Therapies
Countries
1
01

Overview

Phase 4, randomised trial of PRGF-Endoret in stasis ulcer (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Ulcer area reduction. Started Mar 2017; status: active.

02

Drugs

PRGF-Endoret
03

Conditions

stasis ulcer

Beyond the preview

Go deeper on 2017-000314-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000314-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call